Detection of Group A β-Hemolytic Streptococci in Oral Samples

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-18

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, sample collection study will assess different oral and/or nasal sample types collected from patients suspected of suffering from GABHS pharyngitis to conduct research and development on innovative GABHS detection methods specific for each sample type.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Detection of GABHS in Throat Gargle

NCT03231098

Group A Streptococcus: B Hemolytic Pharyngitis

COMPLETED

Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.

NCT03422341

Pharyngitis, Infective

COMPLETED NA

Clinical Performance of the Checkable Medical At-Home Strep A Test

NCT05107362

Streptococcus Pyogenes Infection Pharyngitis Respiratory Tract Infections

COMPLETED

Time Frame for GBS Screening

NCT04116645

GBS Group B Streptococcal Infection

WITHDRAWN

A Multi-Site Clinical Evaluation of the ARIES Group A Strep Assay in Symptomatic Patients

NCT03037957

Pharyngitis Bacterial

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study candidates are patients age 3 and older with complaints of sore throat and are suspected of suffering from GABHS pharyngitis. Patients who consent and are found eligible will be enrolled in the study. Subjects will be tested according to the conventional standard of care in addition to providing extra specimen samples for the study.

After each patient has been tested according to conventional SOC and has enrolled in the study, up to ten oral and/or nasal specimen samples will be collected . Study participation is complete once all specimen samples are collected.

Most or all collected samples will be qualitatively tested and may also be quantitatively and/or semi-quantitatively tested for the presence of GABHS. Some collected samples may additionally or alternatively be tested for other respiratory infections as well. (such as SARS-CoV-2, influenza, etc.)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Group A β-Hemolytic Streptococci

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oral and/or nasal specimen samples

After each patient has been tested according to conventional SOC and has enrolled in the study, up to ten oral and/or nasal specimen samples will be collected

Collection of oral and/or nasal samples

Intervention Type OTHER

Collection of oral and/or nasal samples after SOC test performed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Collection of oral and/or nasal samples

Collection of oral and/or nasal samples after SOC test performed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient, either male or female, is age 3 years or older;
2. Patient is suspected of suffering from GABHS pharyngitis, and is prescribed a throat culture by conventional SOC;
3. Patient or legal guardian is able to communicate with study personnel;
4. Patient or legal guardian is able to understand oral and written information regarding the nature of the study and is willing to provide written informed consent.

Exclusion Criteria

1. Patients presently on antibiotics prescribed by a physician for treatment or prevention of GAS infection or has taken antibiotics within the past 3 days ( unless patient only first started taking antibiotics within the past 24 hour)
2. pregnancy
3. Patients who took mouth rinse or taking oral treatment for mouth sores within 3 hours of study

Minimum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No